| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 07/14/2004 | EP1435949A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435942A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435933A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435928A1 Allicin |
| 07/14/2004 | EP1435924A2 Therapeutic composition and use |
| 07/14/2004 | EP1140102B1 Triazineone compounds for treating diseases due to neospora and toxoplasma |
| 07/14/2004 | EP0961775B1 Purine l-nucleosides, analogs and uses thereof |
| 07/14/2004 | CN1512983A Compounds and compositions as cathepsins inhibitors |
| 07/14/2004 | CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents |
| 07/14/2004 | CN1512894A Monocyte specific particulate delivery vehicle |
| 07/14/2004 | CN1512880A Novel compounds and compositions as cathepsin inhibitors |
| 07/14/2004 | CN1511588A Japanese blood fluke nucleic acid vaccine |
| 07/14/2004 | CN1157381C Dicyclanil polymorphs and hydrates and their preparation |
| 07/14/2004 | CN1157212C Veterinary liniment containing azedarine and its preparation |
| 07/13/2004 | US6762175 Fatty acid derivatives |
| 07/13/2004 | US6762164 Use of 3-position cyclosporin derivatives for hair growth |
| 07/13/2004 | CA2064117C 4"-and 4'-alkylthio-avermectin derivatives |
| 07/08/2004 | WO2004056844A1 Avermectin b1 and avermectin b1 monosaccharide derivatives having an alkoxymethyl substituent in the 4”- or 4’-position |
| 07/08/2004 | WO2004056828A2 Novel compounds and uses thereof |
| 07/08/2004 | WO2004056376A1 Pharmaceutical formulations containing nitrate |
| 07/08/2004 | WO2004035611A8 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 07/08/2004 | WO2003070192A3 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 07/08/2004 | WO2002097060A3 Carbohydrate-associated proteins |
| 07/08/2004 | US20040132788 thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives; treating neurodegenerative disorders or pain. |
| 07/08/2004 | US20040132694 6-Chloro-3-(3,4-dioxo-2-phenylamino-cyclobut-1-enylamino)-2-hydroxy-benzamide; psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease |
| 07/08/2004 | US20040132685 Immunostimulatory nucleic acid |
| 07/08/2004 | US20040132163 Biological materials and uses thereof |
| 07/08/2004 | US20040132038 Membrane protein for use as diagnostic tool in the detection and prevention of cell proliferative, cardiovascular, skin, nervous system, respiratory and metabolic disorders |
| 07/08/2004 | US20040132028 Collection of repeat proteins comprising repeat modules |
| 07/08/2004 | US20040131703 Antiinflammatory agents; respiratory system disorders |
| 07/08/2004 | US20040131650 Mixture containing viral, bacteria, parasitic antigen |
| 07/08/2004 | US20040131594 Malaria therapy; using pox virus vectors; genetic engineering; antitumor agents |
| 07/07/2004 | EP1434886A2 Mid 241 receptor, a novel g-protein coupled receptor |
| 07/07/2004 | EP1434859A2 Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 07/07/2004 | EP1434796A2 Secreted proteins |
| 07/07/2004 | EP1434788A2 Proteins associated with cell growth, differentiation, and death |
| 07/07/2004 | EP1434785A2 Protein modification and maintenance molecules |
| 07/07/2004 | EP1434760A2 Carbonyloxy-cyanomethyl compounds as antiparasitic agents |
| 07/07/2004 | EP1434485A1 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
| 07/07/2004 | EP1230222B1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 07/07/2004 | EP0907373B1 Use of synergistic compositions of il-12 and ifn-alpha for the treatment of infectious diseases |
| 07/07/2004 | CN1511155A Amido ether substituted imidazoquinolines |
| 07/07/2004 | CN1511137A Hydro phobic polyamine analogs and methods for their use |
| 07/06/2004 | US6759407 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, ESP as parasiticides |
| 07/06/2004 | US6759044 Cryptopain antibodies for prophylaxis, treatment, diagnosis and detection of Cryptosporidium species |
| 07/06/2004 | US6759036 Fibrocyte-base vaccine formulations |
| 07/06/2004 | CA2235902C Method for treating protozoal infections |
| 07/01/2004 | WO2004013093A3 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 07/01/2004 | US20040127548 thiophene derivative paraciticides |
| 07/01/2004 | US20040127454 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases |
| 07/01/2004 | US20040127438 polypeptide (or its encoding nucleic acid molecule from Mycobacterium tuberculosis or related prokaryotes in the treatment of cancer, allergic disorders or conditions of immunoactivation, particularly asthma |
| 07/01/2004 | US20040127429 glycolipid ligand for natural killer T (NKT) cells; synthetic analogs of alpha -C-galactosylceramides |
| 07/01/2004 | US20040127424 Inhibitors of cruzipain and other cysteine proteases |
| 07/01/2004 | US20040126759 Molecules for disease detection and treatment |
| 07/01/2004 | US20040126403 Treatment for ectoparasites |
| 06/30/2004 | EP1432788A2 Live attenuated salmonella strains for producing vaccines |
| 06/30/2004 | EP1432722A2 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 06/30/2004 | EP1432680A1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
| 06/30/2004 | EP1432431A2 Methods and compositions for modulating interleukin-21 receptor activity |
| 06/30/2004 | CN1508251A Malignant malarial parasite msra-3 gene, protein product and use thereof |
| 06/30/2004 | CN1508250A Malignant malarial parasite msra-2 gene, protein product and use thereof |
| 06/30/2004 | CN1508249A Maiignant malarial parasite msra-1 gene, protein product and use thereof |
| 06/30/2004 | CN1507864A Endermatic feeding preparation of anti parastic medicine containing benzimidazole |
| 06/29/2004 | US6756382 Amide substituted imidazoquinolines |
| 06/29/2004 | US6756381 A purified antitumor agent is crystallized from acetone or dichloromethane |
| 06/29/2004 | CA2112399C Methods and compositions for treating malaria and other diseases |
| 06/24/2004 | WO2004052863A1 Anti-inflammatory agent |
| 06/24/2004 | WO2004052400A1 Pharmaceutical formulation and a method of making same |
| 06/24/2004 | WO2004052365A2 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 06/24/2004 | WO2004014304A3 Electrospun amorphous pharmaceutical compositions |
| 06/24/2004 | WO2003083083A3 Methods of using flt3-ligand in immunization protocols |
| 06/24/2004 | US20040122084 7-Methyl-3.6,10,15-tetraoxapentacyclo [12.2.1.02,4. 05,7. 09,13]heptadec-1(17)-ene-11,16-dione derivatives; antitumor, -proliferative, -carcinogenic agents; viricides;DNA polymerase inhibitors; bactericides; solubility; stability; injections |
| 06/24/2004 | US20040122030 Substituted phthalimide and isoquinoline derivatives; thalidomide analogs that lack the piperidine-2,6-dione moiety of thalidomide |
| 06/24/2004 | US20040121345 Identification of a human n-terminal acetyltransferase gene |
| 06/24/2004 | US20040120896 Buccal aerosol sprays or capsules using polar and non-polar solvent which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect |
| 06/24/2004 | US20040120895 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 06/23/2004 | EP1431291A1 1-Aryl-4-cyano-3-cyclopropylpyrazole derivatives as ectoparasiticidal agents |
| 06/23/2004 | EP1430019A1 Sphingolipids |
| 06/23/2004 | EP1429773A1 Process for making substituted pyrazoles |
| 06/23/2004 | CN1507339A Use of 3-position cyclosporin derivatives for hair growth |
| 06/23/2004 | CN1154647C Imidazonephthyridines and their use in inducing cytokine biosynthesis |
| 06/23/2004 | CN1154638C Method for control of arthropods in animals |
| 06/23/2004 | CN1154508C Stimulation of host defence mechanisms against viral challenges |
| 06/22/2004 | US6753332 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 06/22/2004 | US6752981 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to the phosphorus in the c3n2p or c3o2p ring |
| 06/17/2004 | WO2004050092A1 Use of canthin-6-one, plant extracts containing same and derivatives thereof in the treatment of trypanosomiases |
| 06/17/2004 | WO2004043446A3 Combination product for controlling insect pests |
| 06/17/2004 | WO2004030685A3 Use of il-2 receptor antibodies to prevent toxicity associated with amphotericin b antimycotic therapy |
| 06/17/2004 | US20040116501 Treatment of nonallergic rhinitis by selective phosphodiesterase 4 inhibitors |
| 06/17/2004 | US20040116448 Substances for the therapy of diseases caused by highly proliferating cells |
| 06/17/2004 | US20040116419 Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals |
| 06/17/2004 | US20040116361 Antihelminthic anthraquinones and method of use thereof |
| 06/17/2004 | US20040115483 Crystal modification of a cyclic depsipeptide having improved strength |
| 06/17/2004 | US20040115213 Use of IL-2 receptor antibodies |
| 06/16/2004 | EP1427857A2 Mid 4460, a human tyrosine phosphatase family member and uses therefor |
| 06/16/2004 | EP1427841A2 Nucleic acid-associated proteins |
| 06/16/2004 | EP1427287A1 Pesticidal and parasitical di-and trifluorosubstituted alkene compounds |
| 06/16/2004 | EP1140127B1 Antiprotozoal saponins |
| 06/16/2004 | EP1140068B1 Doramectin formulations |